Alerts will be sent to your verified email
Verify Email
BALGOPAL
|
Balgopal Commercial
|
Halder Venture
|
Astal Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
19.17 % | 11.11 % | 5.72 % |
|
5yr average Equity Multiplier
|
1.21 | 5.19 | 1.45 |
|
5yr Average Asset Turnover Ratio
|
0.22 | 1.86 | 0.4 |
|
5yr Avg Net Profit Margin
|
401.47 % | 1.35 % | 3.54 % |
|
Price to Book
|
5.62 | 2.19 | 7.26 |
|
P/E
|
0.0 | 78.55 | 32.39 |
|
5yr Avg Cash Conversion Cycle
|
4318.31 Days | 115.43 Days | 83.93 Days |
|
Inventory Days
|
1685.56 Days | 76.19 Days | 12.25 Days |
|
Days Receivable
|
0.0 | 65.32 Days | 123.54 Days |
|
Days Payable
|
58.43 Days | 23.45 Days | 125.63 Days |
|
5yr Average Interest Coverage Ratio
|
1370.87 | 3.07 | 21.93 |
|
5yr Avg ROCE
|
20.78 % | 25.82 % | 7.95 % |
|
5yr Avg Operating Profit Margin
|
-59.92 % | 4.63 % | 4.11 % |
|
5 yr average Debt to Equity
|
0.01 | 2.76 | 0.08 |
|
5yr CAGR Net Profit
|
n/a | 29.92 % | 289.2 % |
|
5yr Average Return on Assets
|
15.89 % | 2.34 % | 3.24 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
45.43 % | 73.84 % | 18.19 % |
|
Share Pledged by Promoters
|
0.75 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
39.12 % | 8.16 % | -49.99 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Balgopal Commercial
|
Halder Venture
|
Astal Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|